Defeating Degeneration I: Virtual Lab Tour/Discussion at Denali Therapeutics

October 25, 2020, 11:00 am

12:00 pm

Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and ALS, are one of the largest medical challenges of our time.

Ever wonder how scientists and physicians are tackling this devastating set of brain disorders?
Curious as to how scientific discoveries translate to new therapies for patients?

Denali Therapeutics is a biotechnology company dedicated to defeating neurodegeneration through rigorous therapeutic discovery and development. We invite you to attend a virtual tour of our laboratories followed by a live Q&A panel discussion with scientists and clinicians representing diverse roles within our drug development team!

Intro Video

On Demand Video


Add to Your Favorites

Add to Your Calendar


Target Audience


Restricted Content

The content for this session is only available to registered users. Not registered? Sign up here.

Watch a Recording of this Event

Resources / Documentation / Files

Event Host

At Denali Therapeutics, we are a team dedicated to defeating degeneration. Neurodegenerative diseases affecting the brain and spinal cord are among the largest medical challenges of our time. Recent groundbreaking scientific insights into the genetic causes and biological processes underlying this class of disorders (e.g. Alzheimer’s disease, Parkinson’s disease, ALS) offer an unprecedented opportunity for the discovery and development of effective medicines. At Denali, we are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop new therapeutics that will change the lives of patients suffering from neurodegenerative disease.